| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EMR | Common Stock | Award | +14,790 | +21% | 84,024 | 04 Nov 2024 | Direct | F1, F2 | ||
| transaction | EMR | Common Stock | Tax liability | $712,488 | -6,530 | -7.8% | $109.11 | 77,494 | 04 Nov 2024 | Direct | F3, F4 |
| transaction | EMR | Common Stock | Award | +5,734 | +7.4% | 83,228 | 04 Nov 2024 | Direct | F5, F6 | ||
| holding | EMR | Common Stock | 4,806 | 04 Nov 2024 | 401(k) plan | ||||||
| holding | EMR | Common Stock | 2,250 | 04 Nov 2024 | 401(k) excess plan |
| Id | Content |
|---|---|
| F1 | Acquisition of shares pursuant to Rule 16b-3 upon payout of 14,790 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2024. |
| F2 | Price is not applicable to the acquisitions described in Note 1. |
| F3 | Shares withheld for required minimum taxes upon vesting of units under a performance share award described in Note 1. |
| F4 | Fair market value on date of withholding described in Note 1. |
| F5 | Grant to Reporting Person of 5,734 restricted stock units under shareholder approved benefit plan pursuant to Rule 16b-3(d). |
| F6 | Price is not applicable to acquisitions resulting from grants of restricted stock units. |